A

Aquestive Therapeutics
D

AQST

3.52000
USD
-0.08
(-2.22%)
Market Closed
Volume
27,222
EPS
-0
Div Yield
-
P/E
-8
Market Cap
320,947,239
OverviewSignalsIdeasNews
Related Instruments
    B
    BHC
    0.16000
    (2.14%)
    7.64000 USD
    B
    BMRN
    0.430
    (0.65%)
    66.670 USD
    L
    LQDT
    0.500
    (1.60%)
    31.670 USD
    L
    LXRX
    -0.07220
    (-8.75%)
    0.75320 USD
    O
    OMER
    -0.110
    (-1.09%)
    10.000 USD
    R
    RUBY
    0.000000
    (0.00%)
    0.000000 USD
    S
    SUPN
    -0.020
    (-0.06%)
    35.570 USD
    V
    VKTX
    -0.155
    (-0.37%)
    42.160 USD
    More
News

Title: Aquestive Therapeutics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.